Celgene Corporation (CELG): Price and Financial Metrics
CELG Stock Summary
- CELG has a market capitalization of $76,722,820,944 -- more than approximately 97.56% of US stocks.
- Of note is the ratio of NA's sales and general administrative expense to its total operating expenses; merely 19.72% of US stocks have a lower such ratio.
- The volatility of NA's share price is greater than that of just 16.22% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to NA are GILD, BMY, QCOM, ADI, and AMAT.
CELG Stock Price Chart Interactive Chart >
CELG Price/Volume Stats
|Current price||$108.24||52-week high||$110.70|
|Prev. close||$108.13||52-week low||$58.59|
|Day high||$108.59||Avg. volume||7,709,665|
|50-day MA||$103.23||Dividend yield||N/A|
|200-day MA||$95.60||Market Cap||77.04B|
Celgene Corporation (CELG) Company Bio
Celgene is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company was founded in 1980 and is based in Summit, New Jersey.